1:09

In this brief two‑speaker discussion, Speaker A introduces Prima, an ocular brain‑computer interface (BCI) developed by entrepreneur Max Hodak—formerly president of Neuralink—that has received European regulatory approval to treat age‑related macular degeneration (AMD). The device is implanted behind the retina; it converts visual information into electrical stimulation of the remaining retinal cells, which then relay signals through the optic nerve to the visual cortex, effectively restoring central vision. Clinical data show an average gain of five lines on a standard eye chart after twelve months of use. Speaker B frames the technology in sci‑fi terms, likening it to a Borg ocular implant, and argues that approaches avoiding direct brain electrode placement are more scalable toward mass‑market consumer devices. The conversation highlights the intersection of cutting‑edge neurotechnology, regulatory milestones, and future market considerations.

Chapters

More from Carlo

0:50
youtube.com

The 1999 Advice That Explains Today's AI Investment Boom

3w ago
1:21
youtube.com

Why the Future of Work Looks a Lot Like Iron Man

3w ago
1:21
youtube.com

One Simple Analogy for Why Automation Fears Are Overblown

3w ago
1:27
youtube.com

The Four Things Society Does Once Its Needs Are Met

3w ago
2:06:21
youtube.com

Robinhood's Vlad Tenev on Tokenizing Everything, OpenAI's 6 Misalignment Reports, Figure's Robot

3w ago
0:43
youtube.com

Why Leaving for a PhD Might Be a Mistake

3w ago
0:47
youtube.com

Why AGI Isn't the Finish Line

4w ago
1:10
youtube.com

The UK Still Can't Get the Model

4w ago
0:38
youtube.com

A Sword Duel Challenge to Elon and Jeff Bezos

4w ago
2:21:55
youtube.com

Frontier Labs Want to Slow Down, OpenAI Delays Its 2026 IPO, Anthropic Flags 5 Bioweapon Cases

4w ago
1:05
youtube.com

GDP Growth Is About to Look Like a Broken Compass

4w ago
See all content